DMC Biotechnologies, Inc. has raised $18.0M to push its precision fermentation platform further into the business of making chemicals. The U.S. biomanufacturer is betting that biology can replace the conventional routes behind everyday ingredients and industrial compounds.
The company's Dynamic Metabolic Control⢠technology is designed to make fermentation more predictable and robust, a pitch aimed at decarbonizing chemicals while improving supply chain security. Inceptional Partners and Sofinnova Partners are backing the round.













